Concepedia

Publication | Open Access

Rosuvastatin Attenuates Progression of Atherosclerosis and Reduces Serum IL6 and CCL2 Levels in Apolipoprotein-E-deficient Mice

DOIFull Paper Access

12

Citations

11

References

2023

Year

Diamantis I. Tsilimigras, Kalliopi Thanopoulou, Maria Salagianni, Gerasimos Siasos, Evangelos Oikonomou, DESPINA D. PERREA, Nikolaos Nirakis, Konstantinos Filis, Konstantinos Tsioufis, Dimitrios Tousoulis,
In Vivo

Abstract

Serum IL6 and CCL2 levels might potentially be used as clinical markers of progression of atherosclerosis during statin treatment for hypercholesterolemia.

References

YearCitations

Page 1